crypto coins info Top searches

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.South Korea's opposition parties condemned Yin Xiyue's office for preventing the police from searching.On the 11th, the 10-year treasury bond futures fell by 0.09%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract 10-year treasury bond futures closed at 2503, up or down by -0.09%, with a turnover of 65,600 lots. The position data showed that the top 20 seats were clear, and the difference position was 4,068 lots. The total number of 10-year treasury bond futures contracts was 69,300 lots, a decrease of 26,600 lots from the previous day. The first 20 seats in the contract held 176,000 lots, a decrease of 3,678 lots from the previous day. The short positions in the top 20 seats of the contract were 181,200 lots, a decrease of 713 lots from the previous day. (Sina Futures)

Market News: The Knesset group approved a bill to increase deficit ratio's GDP to 7.7%, which will be submitted to the Knesset plenary session for voting.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Port-au-Prince Airport in Haiti will resume normal operation. On December 10th, local time, Haitian Aviation Management Committee announced that Toussaint Louvertur International Airport in Port-au-Prince will resume normal operation on the 11th. Toussaint Louverture International Airport, located in Port-au-Prince, Haiti, is the largest airport in the country. In March this year, Haitian gang militants attacked the airport in an attempt to seize control. Since then, the operation of the airport has been blocked, and most airlines have cancelled flights to Haiti. (CCTV News)

The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.AKIRA AMARI, a former Japanese parliamentarian, said that relying on TSMC alone for high-end chips is the biggest risk.Hauser, Vice Chairman of the Reserve Bank of Australia: The direct impact of US tariffs on Australia may be limited. Hauser: Australia has a strong comparative advantage in raw materials and services. Flexible exchange rate and independent monetary policy are powerful shock absorbers. The Reserve Bank of Australia will respond in any direction to fulfill its responsibilities. The impact of (Trump policy) on inflation in Australia is ambiguous and may move in any direction. We will pay close attention to the progress of tariffs and stand ready to respond appropriately.